“a nonsignificant trend”

Exploratory End Points Lean body mass/fat mass ratio was increased significantly in the DCCR group compared to the placebo group (see Table 2 ; P = .001), with a significant reduction in body fat mass in the DCCR group compared to the placebo group (see Table 2 ; P = .003) and a nonsignificant trend toward an increase in lean body mass (see Table 2 ; P = .058).

There was a nonsignificant trend for ΔSR in the middle frequency to improve relative to the slow frequency (p = 0.058).

Serum sodium concentration increased significantly from the beginning to the end of exercise in both MOD and HI sessions (time effect: p = 0.003) and decreased during recovery (time effect: p < 0.0001), with a nonsignificant trend towards higher serum sodium in MOD versus HI during both exercise (treatment effect: p = 0.058, interaction: p = 0.62) and recovery (treatment effect: p = 0.08, interaction: p = 0.56) ( Figure 1 C).

In addition, this model confirmed the positive effect of affiliation score, albeit as a nonsignificant trend only (GLMM, β ± SE = −0.034 ± 0.018, F 1,167 = 3.638, p = 0.058).

Results Gaze cueing Error rates in Experiment 2 were low, and although accuracy was slightly higher in response to valid gaze cues ( M = 97.29%, SE = 2.96) than invalid ( M = 96.29%, SE = 3.45), this difference was a nonsignificant trend, t (29) = 1.97, 95% CI [−0.00, 0.02], p = .058, d = 0.73.

We found a nonsignificant trend for β power to differ between tetrodes (Kruskal-Wallis, χ 2 (11) = 19.12, p = 0.058).

Adjuvant chemotherapy was associated with a nonsignificant trend toward reduced DFS (HR 3.21; 95% CI, 0.96–10.69; p = 0.058).

We found a nonsignificant trend for a lower kappa ( p = 0.058) and leaf fraction ( p = 0.092) in BD compared to SCZ.

A nonsignificant trend of increased RA disease duration was observed in patients with RA + osteoporosis (14 vs. 11 years, p = 0.058) and a higher frequency of anti-MCV antibodies (66.2% vs. 50.6%, p = 0.053).

Our results found a nonsignificant trend for correlation between adiponectin and HDL levels (R = 0.47, p= 0.058).

During correct decisions, pilots over the age of 45 showed a nonsignificant trend for greater activity in the bilateral caudate compared to younger pilots ( p = .058; ES = 0.39).

Using multivariable regression analyses significant relationships were found between the MERS-R Total Rigidity Subscale Score and proinflammatory cytokine IL-18 (p = 0.02), and a nonsignificant trend was found between it and IFN-alpha2 (β = −4.982, p = 0.058).

Posterior communicating artery aneurysms showed a nonsignificant trend to be more abundant in women (10.10%) than in men (6.80%; OR, 1.555; P = 0.0581).

In our study, there was a nonsignificant trend toward differences in UGIH mortality between AT and non-AT users (4.6% vs. 2.9%, respectively; P = 0.0584).

Among single DISE patients, there was a nonsignificant trend toward decreasing total AHI ( P = .059).

There was a nonsignificant trend towards improved survival for patients with GTR (HR = 0.62, P = .059) and significantly improved survival for patients receiving proton radiation (HR = 0.50, P = .019), but neither of these factors was associated with improved PFS.

A nonsignificant trend was observed in the left medT for the singer—control contrast ( p = 0.059; Figure 6C ).

In an exploratory analysis of the overall GC registry cohort ( n = 1801 with available OS data), ASXL1 showed a nonsignificant trend toward better OS from C-CAT registration (HR 0.71, 95% CI 0.50–1.01, P = 0.059) (Supplementary Fig.

Younger menarcheal age showed a nonsignificant trend with younger age at onset in univariable linear regression (Slope coefficient: 0.3, 95% CI: −0.0, 0.6; P = 0.059).

Peripheral artery disease (PAD) was a strong predictor of diabetes distress (AOR 6.03, 95% CI 1.79–23.29; p = 0.005), while prior TIA or stroke showed a nonsignificant trend (AOR 3.20, 95% CI 0.98–11.50; p = 0.059).

There was a nonsignificant trend for investigation of 5% food odor + laser to be less than that for 5% food odor alone ( p = 0.059) s .

We found a nonsignificant trend towards decreased patient survival (HR = 1.81, 95% CI 0.98–3.34 p = 0.059) but no effect on allograft survival (HR 1.51, 95% CI 0.85–2.68, p = 0.20). 4.

For the non-dominant eye, AULCSF, CS at 6 cpd, 12 cpd, and 18 cpd all improved significantly, whereas CS at 3 cpd showed a nonsignificant trend ( P = 0.059).

Multisystem failure showed a nonsignificant trend toward higher incidence in diabetics (2.8% vs. 0.5%, p = 0.059) (Table 3 ). 3.1.

The only clinically relevant difference in clinicopathological characteristics between the 2 treatment periods was a smaller mean tumor diameter in the later cohort ( P = 0.003), which was associated with a nonsignificant trend toward a lower AFIP score ( P = 0.059).